multivariate regression analyses also were performed. University of Texas M. D. Anderson Cancer Cen-RESULTS. Median follow-up time was 111 months. Four of 7 evaluable patients ter, Houston, Texas. who had second-look surgery (57%) had a response to chemotherapy. Twelve of
Serous ovarian tumors of low malignant potential with peritoneal implants
β Scribed by David M. Gershenson; Elvio G. Silva
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 943 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with noninvasive peritoneal implants, with the objectives of gaining additional insight into the biologic behavior of these tumors and understanding better the effects
## Abstract ## BACKGROUND. Methylationβmediated suppression of detoxification, DNA repair, and tumor suppressor genes has been implicated in cancer development and progression. Studies also have indicated that concordant methylation of multiple genes (methylator phenotypes), rather than a single g
## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme